Literature DB >> 3180536

Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia.

J W Bijlsma1, J A Raymakers, C Mosch, A Hoekstra, R H Derksen, H Baart de la Faille, S A Duursma.   

Abstract

Bone-loss in glucocorticoid-induced osteopenia is most evident in trabecular bone such as the vertebrae. Bone mineral content (BMC) measurements of the spine were prospectively studied, comparing the preventive effect of calcium (500 mg a day) and calcium plus Vitamin D (4000 IU on alternate days) during long-term corticosteroid treatment. A small increase in BMC was noted in both groups, but no differences between preventive calcium and calcium plus Vitamin D became evident. It is suggested that patients who are receiving prednisone should be advised to use supplemental calcium.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3180536

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  18 in total

1.  Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology.

Authors:  E M Scott; I Gaywood; B B Scott
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

Review 2.  Prevention and treatment of glucocorticoid-induced osteoporosis.

Authors:  F Eggelmeijer
Journal:  Pharm World Sci       Date:  1998-10

3.  Glucocorticoid-induced osteoporosis: treatment update and review.

Authors:  Lisa-Ann Fraser; Jonathan D Adachi
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-04       Impact factor: 5.346

4.  Prevention of glucocorticoid induced osteoporosis.

Authors:  J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1997-09       Impact factor: 19.103

5.  Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis.

Authors:  W F Lems; W G Jacobs; J W Bijlsma; A Croone; H C Haanen; H H Houben; M I Gerrits; H J van Rijn
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

6.  Multiple sites of ischemic necrosis of bone following long term corticosteroid treatment in a patient with auto-immune granulocytopenia.

Authors:  H J van Leeuwen; D Witkamp; L F Verdonck; O Huber-Bruning; M J van der Veen; J W Bijlsma
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

7.  Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club.

Authors:  Jean-Pierre Devogelaer; Stefan Goemaere; Steven Boonen; Jean-Jacques Body; Jean-Marc Kaufman; Jean-Yves Reginster; Serge Rozenberg; Yves Boutsen
Journal:  Osteoporos Int       Date:  2005-10-11       Impact factor: 4.507

Review 8.  Corticosteroid-Induced osteoporosis: detection and management.

Authors:  J D Adachi; A Papaioannou
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 9.  Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies.

Authors:  R N J de Nijs; J W G Jacobs; A Algra; W F Lems; J W J Bijlsma
Journal:  Osteoporos Int       Date:  2004-05-07       Impact factor: 4.507

10.  Effects of different regimes of corticosteroid treatment on calcium and bone metabolism in rheumatoid arthritis.

Authors:  M J van der Veen; J W Bijlsma
Journal:  Clin Rheumatol       Date:  1992-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.